App is temporarily unavailable

myCalibra

Companion app to Calibra™

Published by: Hemalytic
Downloads
Revenue

Description

A mobile application designed for patients with Hemophilia and using Hemlibra. myCalibra enables you to track and edit your infusions (dose and time), record bleeds, review your treatment plan and even share your completed logs with your Doctor. The Calendar function helps you avoid missed treatments by sending you notifications of your next scheduled infusion.
Hide Show More...

Screenshots

myCalibra FAQ

  • Is myCalibra free?

    Yes, myCalibra is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is myCalibra legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does myCalibra cost?

    myCalibra is free.

  • What is myCalibra revenue?

    To get estimated revenue of myCalibra app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Brazil yet.
Ratings History

myCalibra Reviews

No Reviews in Brazil
App doesn't have any reviews in Brazil yet.

myCalibra Competitors

Name
mAPPHemo
One Track Health
Track Your CKD Test Results
HaemActive®
Fitness-app for haemophilia
myPKFiT
READ APP INFO BEFORE DOWNLOAD
Hemophilia Connect
myWAPPS
Record. Track. Monitor.
Docintel
N/A
Bayer infuSET
myPROBE
Patient Reported Outcome App
Nanbar

myCalibra Installs

Last 30 days

myCalibra Revenue

Last 30 days

myCalibra Revenue and Downloads

Gain valuable insights into myCalibra performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Publisher
Hemalytic
Languages
English
Recent release
1.1 (3 years ago )
Released on
Jun 24, 2021 (3 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.